Pay in 4 interest-free payments of $5.00 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Comparison CompoundClassPathway / targetResearch focusFormat GHK-CuCopper tripeptideCopper-binding / matrix signallingDermal & connective-tissue remodellingVial GHK-Cu CapsulesCopper tripeptideCopper-binding / matrix signallingOral-route dermal researchCapsules AHK-CuCopper tripeptide (GHK-Cu analogue)Copper-binding / matrix signallingComparative copper-peptide researchVial AHK-Cu CapsulesCopper tripeptide (GHK-Cu analogue)Copper-binding / matrix signallingOral-route comparative researchCapsules Melanotan I (Afamelanotide)Melanocortin peptide (alpha-MSH analogue)MC1RPigmentation-biology & receptor researchVial Melanotan IIMelanocortin peptide (alpha-MSH analogue)MC1R / MC3R / MC4RMelanocortin-receptor signalling researchVial PT-141 (Bremelanotide)Melanocortin peptideMC4RCentral melanocortin-pathway researchVial Every compound in this category is supplied as Research Use Only material with: Peer-reviewed literature underpinning this category
Management and clinical outcome of penetrating keratoplasty for long-term corneal changes in sympathetic ophthalmia
Some protocols extend to 8-12 weeks with longer off periods
Kawana S, Nakagawa K, Hasegawa Y, Kobayashi H, Yamaguchi S
The symptoms experienced are typically functional rather than indicative of mucosal damage or inflammation
US$ 28.56
US$ 20.61
US$ 29.96
US$ 26.98
US$ 22.11
US$ 27.30
US$ 22.10
